Michael Porter Jr. Joins INDIBA as an Athletic Ambassador

BARCELONA, Spain, May 7, 2025 /PRNewswire/ — INDIBA, a global leader in TECAR, laser and regenerative medicine solutions, is proud to announce NBA forward Michael Porter Jr. as its newest athletic ambassador. Porter, known for his resiliency, remarkable athleticism, and mental health advocacy, will represent INDIBA in its mission to promote physical well-being.

Porter, who plays for the Denver Nuggets, is no stranger to overcoming physical challenges. After undergoing three back surgeries in five years, he returned to the court to play a pivotal role in the Nuggets’ 2023 NBA Championship run. With impressive averages of 18.2 points, 7.0 rebounds, and 50.4% shooting from the field this season, Porter’s journey is an inspiring testament to perseverance, making him an ideal ambassador for INDIBA, which is renowned for its innovative solutions in rehabilitation and recovery.

“I’m excited to be partnering with INDIBA, a brand that aligns with my commitment to improving physical and emotional well-being,” said Michael Porter Jr. “The resilience I’ve developed through my journey mirrors the benefits of INDIBA’s treatments in recovery. I look forward to sharing my experiences and spreading the word about how INDIBA can help athletes and everyday people live better, healthier lives.”

INDIBA, headquartered in Barcelona, has been at the forefront of medical advancements for 40 years. The company’s expertise in TECAR technology spans across various sectors, including Aesthetics, Rehabilitation, Intimate Health, Veterinary, and Pharma.

“We are thrilled to welcome Michael Porter Jr. to the INDIBA family,” said Remco Schmitz, INDIBA CEO. “Michael exemplifies the values of strength, resilience, and a commitment to both physical and mental well-being, which align perfectly with our mission to enhance recovery and improve quality of life. His partnership with INDIBA will help us further promote our vision to support individuals in their wellness journey, no matter the challenge.”

For more information about INDIBA and its products, please visit www.indiba.com.

About INDIBA

INDIBA is based in Barcelona and Treviso, with a 40-year legacy in Radiofrequency and regenerative medicine solutions for Aesthetics, Rehabilitation, Intimate Health, Veterinary, and Pharma. The company is renowned for its scientific research and innovation, providing cutting-edge technologies that improve health and well-being. INDIBA recently merged with K-Laser, expanding its product portfolio, medical research, and geographical presence while further advancing the use of laser technologies in healthcare.

View original content to download multimedia:https://www.prnewswire.com/news-releases/michael-porter-jr-joins-indiba-as-an-athletic-ambassador-302448739.html

SOURCE INDIBA

Staff

Recent Posts

Attune to Support Poppy Health’s $39M ARPA-H BREATHE Project in the U.S. Schools

VIENNA, Va., Dec. 19, 2025 /PRNewswire/ -- Attune announced today that the company will play…

3 hours ago

Feel30 Launches Austin-Based Telehealth Platform for Evidence-Proven TRT & Integrated At-Home Phlebotomy Services

AUSTIN, Texas, Dec. 19, 2025 /PRNewswire/ -- Feel30 , a telehealth platform specializing in testosterone…

3 hours ago

LISA LING JOINS TENDERCARE AS CHIEF CAREGIVER ADVOCATE & ADVISOR

– Will help address the difficult realities sandwich generation caregivers face with family caregiving –NEW…

3 hours ago

TENDERCARE LAUNCHING NATIONAL FAMILY CAREGIVING INFRASTRUCTURE, PARTNERING WITH THE AGING LIFE CARE ASSOCIATION® AND SUPPORTING THE CMS GUIDE MODEL PROGRAM

tendercare partnering with ALCA to raise national caregiving and eldercare industry standards;Selected as CMS GUIDE…

3 hours ago

HCAP Partners Announces Investment in Puzzle Healthcare

Investment to accelerate the growth of a post-acute care platform focused on reducing hospital readmissions…

3 hours ago

The Caris Precision Oncology Alliance Welcomes Providence Swedish Cancer Institute

IRVING, Texas, Dec. 19, 2025 /PRNewswire/ -- Caris Life Sciences® (NASDAQ: CAI), a leading, patient-centric, next-generation…

3 hours ago